UnitedHealth Group Stock Rating Reaffirmed by Zacks (UNH)
UnitedHealth Group (NYSE:UNH)‘s stock had its “neutral” rating restated by Zacks in a research note issued to investors on Monday, AR Network reports. They currently have a $80.00 target price on the stock. Zacks‘s price target would indicate a potential upside of 5.57% from the stock’s previous close.
Zacks’ analyst wrote, “UnitedHealth’s first-quarter 2014 earnings beat the Zacks Consensus Estimate by a penny but decreased 31.3% year over year. UnitedHealth suffered during the quarter due to Medicare Advantage rate cuts and new taxes imposed by the Affordable Care Act. We, however, praise UnitedHealth for following a differentiated growth strategy by building on its business from Optum, which offers higher margin contribution and also has the potential to contribute to the company’s long-term growth UnitedHealth has also successfully maintained its medical cost ratio at levels within the Obamacare mandated range of 80-85%. However, Medicare reimbursement cuts, industry fees and taxes, and higher operating costs are some of the headwinds facing the company. Nevertheless, capital strength and a niche market position are some of the positives that UnitedHealth should benefit from. We thus maintain our Neutral recommendation on the stock. “
A number of other firms have also recently commented on UNH. Analysts at Deutsche Bank cut their price target on shares of UnitedHealth Group from $90.00 to $85.00 in a research note on Monday. They now have a “buy” rating on the stock. Separately, analysts at Jefferies Group cut their price target on shares of UnitedHealth Group from $89.00 to $87.00 in a research note on Monday. Finally, analysts at CRT Capital raised their price target on shares of UnitedHealth Group from $80.00 to $90.00 in a research note on Monday. They now have a “buy” rating on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $81.72.
UnitedHealth Group (NYSE:UNH) traded down 1.10% during mid-day trading on Monday, hitting $74.95. The stock had a trading volume of 6,912,457 shares. UnitedHealth Group has a one year low of $58.12 and a one year high of $83.32. The stock has a 50-day moving average of $79.35 and a 200-day moving average of $74.17. The company has a market cap of $74.650 billion and a P/E ratio of 13.91. UnitedHealth Group also was the recipient of unusually large options trading activity on Monday. Stock traders acquired 4,464 put options on the company. This represents an increase of 157% compared to the typical daily volume of 1,738 put options.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The company reported $1.10 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.09 by $0.01. The company had revenue of $31.70 billion for the quarter, compared to the consensus estimate of $32.03 billion. During the same quarter last year, the company posted $1.16 earnings per share. UnitedHealth Group’s revenue was up 4.5% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group will post $5.57 EPS for the current fiscal year.
UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.